Showing results (351-360 of 368) with videos related to

Sort By:
Pageof 37
European Journal of Cancer (Oxford, England : 1990)|December 7, 2024
Safety and efficacy of adjuvant FOLFOX/FOLFIRI with versus without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastasectomy (HARVEST trial): A randomized controlled trialDe-Shen Wang, William Pat Fong, Lei Wen, et al.
Cancer Medicine|November 15, 2019
Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancerDe-Shen Wang, Zhi-Qiang Wang, Gong Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 25, 2023
Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized TrialLi Xiang, Jin-Feng Rong, Xin-Chen, et al.
Cancer Immunology, Immunotherapy : CII|December 6, 2017
The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastasesYun Wang, Hao-Cheng Lin, Ma-Yan Huang, et al.
International Journal of Surgery (London, England)|April 23, 2024
Long-term outcomes of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection (IOCCRC): a randomized, multicenter, prospective, phase III trialRong-Xin Zhang, Xiao-Jun Wu, De-Sen Wan, et al.
Nature Communications|January 12, 2019
Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progressionGui-Fang Zhu, Yang-Wei Xu, Jian Li, et al.
Cancer Cell|July 25, 2025
Alistipes finegoldii augments the efficacy of immunotherapy against solid tumorsZhi-Ying Wu, Qi-Wen Wu, Yi Han, et al.
Breast Cancer Research : BCR|September 13, 2017
Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumorsImke H Bartelink, Brendan Prideaux, Gregor Krings, et al.
Gut|February 10, 2026
SDC1+ CAFs secreting CTGF drive tumour metastasis via FGFR3 signalling in cancersGuan-Feng Gao, Zhao-Hui Ruan, Shi-Bo Zhang, et al.
Cancer Cell|May 27, 2022
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapiesDenise M Wolf, Christina Yau, Julia Wulfkuhle, et al.
Pageof 37